WHITEHAWK THERAPEUTICS, INC. Deferred Tax Assets, Gross
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Deferred Tax Assets, Gross of $44.69 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2026-03-12
- 2025-12-31: Deferred Tax Assets, Gross $44.69M.
- 2024-12-31: Deferred Tax Assets, Gross $122.29M.
- 2023-12-31: Deferred Tax Assets, Gross $72.70M.
- 2022-12-31: Deferred Tax Assets, Gross $53.35M.
| Period end | Deferred Tax Assets, Gross | Deferred Tax Assets, Gross as first filed |
|---|---|---|
| 2025-12-31 | $44.69M 10-K · filed 2026-03-12 | |
| 2024-12-31 | $122.29M 10-K · filed 2026-03-12 | |
| 2023-12-31 | $72.70M 10-K · filed 2025-03-28 | |
| 2022-12-31 | $53.35M 10-K · filed 2024-03-13 | |
| 2021-12-31 | $39.17M 10-K · filed 2023-03-29 | |
| 2020-12-31 | $10.27M 10-K · filed 2022-03-17 | $32.07M 10-K · filed 2021-03-11 |
| 2019-12-31 | $30.80M 10-K · filed 2021-03-11 | |
| 2018-12-31 | $25.01M 10-K · filed 2020-03-16 | |
| 2017-12-31 | $22.17M 10-K · filed 2019-03-07 | |
| 2016-12-31 | $25.95M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $87.50K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $85.10K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $82.60K 10-Q · filed 2016-05-16 | |
| 2015-09-30 | $76.40K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $74.20K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $71.70K 10-Q · filed 2015-05-13 | |
| 2014-09-30 | $65.80K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $63.60K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $61.20K 10-Q · filed 2014-05-15 | |
| 2013-09-30 | $55.90K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $53.80K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $51.60K 10-Q · filed 2013-05-15 | |
| 2012-09-30 | $46.20K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $44.10K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |